Motley Fool Australia

Recce Pharmaceuticals Ltd (ASX: RCE) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $170.30 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 173.78 million
Earnings per share -0.100
Dividend per share N/A
Year To Date Return -3.79%
Earnings Yield N/A
Franking N/A

Recce Pharmaceuticals Ltd (ASX: RCE) Latest News

asx share price rise represented by excited investor making fist at computer screen

Why Novonix, Recce, Singular Health, & Starpharma shares are storming higher

More »

rising asx share price represented by boy dressed in business suit with rocket wings

Why the Recce Pharmaceuticals (ASX:RCE) share price is rocketing 10% higher

More »

share price higher

Why a2 Milk, Air New Zealand, Mesoblast, & Recce shares are storming higher

More »

Recce (ASX:RCE) share price charges higher on COVID-19 update

More »

hand on touch screen lit up by a share price chart moving higher

Recce (ASX:RCE) share price shoots up 5% on new patent approval

More »

rising asx share price represented by boy dressed in business suit with rocket wings

Why is the Recce (ASX:RCE) share price soaring 14%?

More »

Here’s why the Recce (ASX:RCE) share price has fallen 7% today

More »

The Recce (ASX:RCE) share price has surged up today. Here’s why

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Recce Pharmaceuticals Ltd (ASX: RCE)

Recce Pharmaceuticals Ltd (ASX: RCE) is a global biotechnology company engaged in the development and commercialisation of a new class of antibiotics. It operates in only one business segment, being research and development of pharmaceutical drugs.

Based in Australia, the company also has operations in the United Kingdom, and the United States. Recce offers antibiotic drugs to treat diseases caused by various bacterias including sepsis, Helicobacter pylori, Escherichia coli, Pseudomonas aeruginosa, and others.

With COVID-19 in the backdrop of 2020, the Recce share price has been pushing higher in the last 12 months.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 Mar 2021 $0.98 $-0.03 -2.96% 241,862 $1.00 $1.00 $0.98
04 Mar 2021 $1.02 $-0.02 -1.93% 137,898 $1.04 $1.04 $1.00
03 Mar 2021 $1.04 $0.00 0.00% 272,689 $1.03 $1.04 $1.01
02 Mar 2021 $1.04 $0.01 0.98% 159,005 $1.02 $1.04 $1.02
01 Mar 2021 $1.03 $-0.03 -2.86% 221,431 $1.05 $1.06 $1.02
26 Feb 2021 $1.05 $-0.02 -1.87% 109,095 $1.07 $1.07 $1.04
25 Feb 2021 $1.07 $0.03 2.88% 103,805 $1.05 $1.07 $1.04
24 Feb 2021 $1.04 $-0.01 -0.95% 152,658 $1.06 $1.06 $1.03
23 Feb 2021 $1.05 $0.02 1.94% 147,668 $1.06 $1.06 $1.02
22 Feb 2021 $1.03 $0.02 1.97% 111,420 $1.03 $1.05 $1.02
19 Feb 2021 $1.02 $-0.01 -0.98% 353,609 $1.03 $1.03 $1.02
18 Feb 2021 $1.03 $-0.02 -1.92% 274,340 $1.09 $1.09 $1.03
17 Feb 2021 $1.04 $-0.05 -4.59% 341,012 $1.10 $1.10 $1.04
16 Feb 2021 $1.09 $-0.02 -1.80% 515,891 $1.11 $1.11 $1.05
15 Feb 2021 $1.11 $-0.01 -0.89% 553,999 $1.13 $1.14 $1.09
12 Feb 2021 $1.12 $0.09 8.74% 1,482,780 $1.10 $1.15 $1.06
11 Feb 2021 $1.03 $0.02 1.98% 415,231 $1.03 $1.03 $1.00
10 Feb 2021 $1.01 $-0.01 -0.98% 311,295 $1.03 $1.04 $1.00
09 Feb 2021 $1.03 $-0.03 -2.84% 265,420 $1.06 $1.06 $1.01
08 Feb 2021 $1.06 $0.00 0.00% 268,463 $1.03 $1.06 $1.00
05 Feb 2021 $1.05 $0.05 4.98% 476,013 $1.00 $1.05 $0.99
04 Feb 2021 $1.01 $-0.02 -1.95% 343,473 $1.04 $1.05 $1.01
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
22 Feb 2021 James Graham Issued 2 $2,317,500
22 Feb 2021 Alan Dunton Issued 1 $1,158,750
22 Feb 2021 Michele Dilizia Issued 1 $1,545,000
22 Feb 2021 John Prendergast Issued 2 $2,240,250
22 Feb 2021 Justin Ward Issued 600 $618,000
04 Dec 2020 Alan Dunton Issued 60 $73,200
28 Aug 2020 James Graham Buy 389 $530,008
28 Aug 2020 James Graham Exercise 745 $1,014,508
28 Aug 2020 James Graham Buy 356 $484,500
28 Aug 2020 Michele Dilizia Buy 577 $785,008
28 Aug 2020 Michele Dilizia Exercise 577 $785,008
09 Jul 2020 James Graham Buy 389 $409,197
09 Jul 2020 James Graham Buy 356 $374,062
09 Jul 2020 James Graham Exercise 745 $783,260
09 Jul 2020 Michele Dilizia Buy 577 $606,072
09 Jul 2020 Michele Dilizia Exercise 577 $606,072
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr James Hamilton Bray Graham Executive Director,Chief Executive Officer Jun 2015
Dr Alan William Dunton Non-Executive Director Jul 2020
Ms Michele Keryn Dilizia Executive Director Jun 2015
Dr John Prendergast Non-Executive Director,Non-Executive Chairman Apr 2018
Dr Justin Ward Executive Director Jul 2019
Mr Alistair McKeough Company Secretary Nov 2017
Justin Reynolds Chief Financial Officer
Alistair McKeough Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Mr Graham Melrose & Ms Olga Melrose 36,450,003 25.28%
Mr Ross Gustafson 6,988,402 4.85%
Mr James Graham 5,238,120 3.63%
Acuity Capital Investment Management Pty Ltd <Acuity Capital Holdings A/C> 4,500,000 3.12%
J P Morgan Nominees Australia Pty Limited 4,347,169 3.02%
Ms Michele Keryn Dilizia 3,141,273 2.18%
Querion Pty Ltd 2,100,000 1.46%
Acewood Investments Pty Ltd <Chivers Super Fund A/C> 1,646,154 1.14%
Citicorp Nominees Pty Limited 1,158,556 0.80%
Golden Rivers Mining Pty Ltd 1,154,006 0.80%
Pejay Pty Limited 1,100,000 0.76%
Mr Nikolai Shirobokov & Mrs Svetlana Shirobokov 1,060,414 0.74%
Mr Robert Cerny & Mrs Zaphiero John Cerny <Parez Super Fund A/C> 1,000,000 0.69%
Shortis Natural Therapies Pty Limited <Shortis Family A/C> 1,000,000 0.69%
Mr Leslie John Field & Mrs Eve Field 938,504 0.65%
McCray Investments Pty Ltd <McCray Fam SF A/C> 865,281 0.60%
Mr Mark David Swinn 833,105 0.58%
Mr Christopher James Frisch & Mr Paul Edward Frisch <Fredflint Superfund A/C> 759,433 0.53%
Mr Denis Pierre Geoffrey Pyman <Pyman Super Fund A/C> 700,000 0.49%
Super And Investment Holdings Pty Ltd <Nettleton Family S/F A/C> 650,000 0.45%
Haultain Properties Ltd 550,000 0.38%
Arthur Deryck Bray Graham & Nanette Graham 550,000 0.38%
Show more